论文部分内容阅读
介绍 WHO国际药品监测合作中心和国际医学理事会(CIOMS)在协调欧盟药品安全性监测工作方面发挥的重要作用和发展现状,同时,对法国以各地区ADR监察中心为基础的区域化的药品安全性监察体系作了较详尽地介绍,认为这一体系为整个欧洲未来的药品安全性监察工作制定了蓝图.此外,对收集人群中药品利用的定量信息,建立新的或改进现有数据库系统在开展药物流行病学研究中的作用,对英国处方事件监测(PEM)和荷兰PHARMO 数据库发展现状作了阐述,并介绍了欧盟有关药物流行病学相关学术组织的主要活动.
This paper introduces the important role and development of WHO collaborating center for international drug monitoring and the International Medical Council (CIOMS) in coordinating EU drug safety monitoring. At the same time, it introduces the regional drug safety based on the regional ADR monitoring center The Sex Surveillance System is described in more detail as a blueprint for the future monitoring of drug safety throughout Europe, and in addition to collecting quantitative information on the use of medicines in the population, establishing new or improving existing database systems Carried out the role of pharmacoepidemiological studies, elaborated on the status quo of PEM in the United Kingdom and the development of the PHARMO database in the Netherlands, and introduced the main activities of the EU related academic organizations on pharmaceutical epidemiology.